Prior authorization programs to control medical imaging utilization could wind up costing the government money and increase administrative burden, according to a review by The Moran Company released this week by the Access to Medical Imaging Coalition.
Prior authorization programs to control medical imaging utilization could wind up costing the government money and increase administrative burden, according to a review by The Moran Company released this week by the Access to Medical Imaging Coalition.
“The analysis confirms that a prior authorization policy for the Medicare program would not achieve any real cost savings,” said Tim Trysla, executive director of AMIC. “Contrary to outdated budget estimates being used by some members of Congress, a prior authorization program would end up costing the government more than it saves and would simply delay patient care and impose administrative burdens and increased costs on physician practices.”
Analysts reviewed the cost savings of various proposed imaging policies, prior authorization and decision support tools. Analysts were unable to find any peer-reviewed literature that evaluated the cost effectiveness of prior authorization on inpatient services, and data on authorization for imaging services was “similarly thin,” according to the report.
Further, HHS has previously raised concerns about the administrative burden on prior authorization and the lack of data on the success of radiology benefit managers. It would be difficult to structure such a program in a way that reaps significant savings, the analysts found, adding, “Indeed, it is possible that the returns from prior authorization may be meaningfully smaller than the operating costs of conducting these programs.”
“The Moran analysis confirms that policymakers should be looking elsewhere for cost savings,” Trysla said. “The adoption of physician-developed appropriateness criteria and the use of decision support tools promote cooperation among physicians and are far more effective approaches to ensuring that patients receive the right scan at the right time.”
In the review of decision support tools, the report noted that decision support tools have been shown to reduce the volume of imaging services, but their use isn’t widespread. The Congressional Budget Office hasn’t reviewed proposals for decision support tools, the report stated.
Policymakers should instead consider programs that reduce pay for providers with aberrant ordering patterns, according to the report.
Trysla said in an interview that this report is an independent look at the research showing evidence-based tools have an effect on lowering imaging costs. Instead of relying on prior authorization, image ordering should be based on established appropriateness guidelines, he said.
“It’s where the discussion should be rather than the broad-based cuts” in imaging services, he said. “We hope they won’t look toward prior authorization as a way to cut reimbursement to advanced imaging.”
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
2 Commerce Drive
Cranbury, NJ 08512